JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2005, 54(4):163-167

Methods of Artificial Intelligence: A New Trend in Pharmacy

V. Dohnal1, K. Kuča2, D. Jun2
1 Mendelova zemědělská a lesnická univerzita Brno, Agronomická fakulta, Ústav technologie potravin
2 Univerzita obrany Hradec Králové, Fakulta vojenského zdravotnictví, Katedra toxikologie

Artificial neural networks (ANN) and genetic algorithms are one group of methods called artificial intelligence. The application of ANN on pharmaceutical data can lead to an understanding of the inner structure of data and a possibility to build a model (adaptation). In addition, for certain cases it is possible to extract rules from data. The adapted ANN is prepared for the prediction of properties of compounds which were not used in the adaptation phase. The applications of ANN have great potential in pharmaceutical industry and in the interpretation of analytical, pharmacokinetic or toxicological data.

Keywords: artificial neural networks; molecular descriptors; QSAR; QSP

Received: January 17, 2005; Accepted: February 2, 2005; Published: April 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dohnal V, Kuča K, Jun D. Methods of Artificial Intelligence: A New Trend in Pharmacy. Čes. slov. farm. 2005;54(4):163-167.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. http://www.fda.gov/fdac/special/newdrug/ndd_toc.html
    2. Suter, L., Babiss, L. E., Wheeldon, E. B.: Chem. Biol., 2004; 11, 161-171. Go to original source...
    3. Encyklopedie Wikipedia, http://www.wikipedia.org
    4. Turing, A.: Mind, 1950; 59, 433-460. Go to original source...
    5. Kohonen, T.: Biol. Cybern., 1982; 43, 59-69. Go to original source...
    6. Gasteiger, J., Teckentrup, A., Terfloth, L., Spycher, S.: J. Phys. Org. Chem., 2003; 16, 232-245. Go to original source...
    7. McClelland, J. L., Rumelhart, D. E.: Explorations in parallel distributed processing. Cambridge, MA, MIT Press 1988. Go to original source...
    8. Parrill, A. L.: Drug Discovery Today, 1996; 1, 514-521. Go to original source...
    9. Arcos, M. J., Ortiz, M. C., Villahoz, B., Sarabia, L. A.: Anal. Chim. Acta, 1997; 339, 63-77. Go to original source...
    10. Burden, F. R., Rosewarne, B. S., Winkler, D. A.: Chemom. Intell. Lab. Syst., 1997; 38, 127-137. Go to original source...
    11. Kim, J. H., Jeoung, D., Lee, S., Kim, H.: J. Biomed. Inform., 2004; 37, 260-268. Go to original source... Go to PubMed...
    12. Novič, M., Vračko, M.: Chemom. Intel. Lab. Syst., 2001; 59, 33-44. Go to original source...
    13. Smiths, J. R. M., Schoenmakers, P., Stehmann, A. et al.: Chemom. Intell. Lab. Syst., 1993; 18, 27-29. Go to original source...
    14. Takayama, K., Fujikawa, M., Nagai, T.: Pharm. Res. 1999; 16, 1-6. Go to original source... Go to PubMed...
    15. Gasperlin, M., Tusar, L., Tusar, M. et al.: Int. J. Pharm., 1998; 168, 243-254.
    16. Blake, J. F.: Curr. Opin. Biotechnol., 2000; 11, 104-107. Go to original source... Go to PubMed...
    17. Terfloth, L., Gasteiger, J.: Drug Discovery Today, 2001; 6, 102-108. Go to original source...
    18. Manallack, D. T., Livingstone, D. J.: Eur. J. Med. Chem., 1999; 34, 195-208. Go to original source...
    19. Smith, P. A., Sorich, M. J., Low, L. S. C. et al.: J. Mol. Graphics Modell., 2004; 22, 507-517. Go to original source... Go to PubMed...
    20. Turner, J. V., Maddalena, D. J., Cutler, D. J.: Int. J. Pharm., 2004; 270, 209-219. Go to original source... Go to PubMed...
    21. Butina, D., Segall, M. D., Frankcombe, K.: Drug Discovery Today, 2002; 7, S83-S88. Go to original source... Go to PubMed...
    22. Ekins, S., Rose, J.: J. Mol. Graphics Modell., 2002; 20, 305-309. Go to original source... Go to PubMed...
    23. http://www.hyper.com
    24. Devillers, J., Domine, D., Guillon, C.: Eur. J. Med. Chem., 1998; 33, 659-664. Go to original source...
    25. Jouyban, A., Majidi, M. R., Jalilzadeh, H., Asadpour-Zeynali, K.: Il Farmaco, 2004; 59, 505-512. Go to original source... Go to PubMed...
    26. Agatonovic-Kustrin, S., Zecevic, M., Zivanovic, L.: J. Pharm. Biomed. Anal., 1999; 21, 95-10. Go to original source... Go to PubMed...
    27. Dohnal, V., Li, H., Farková, M., Havel, J.: Chirality, 2002; 14, 509-518. Go to original source... Go to PubMed...
    28. Havel, J., Breadmore, M., Macka, M., Haddad, P. R.: J. Chromatogr. A, 1999; 850, 345-353. Go to original source... Go to PubMed...
    29. Ni, Y., Liu, C., Kokot, S.: Anal. Chim. Acta, 2000; 419, 185-196. Go to original source...
    30. Yamashita, F., Hashida, M.: Adv. Drug Deliver. Rev., 2003; 55, 1185-1199. Go to original source... Go to PubMed...
    31. Sun, Y., Peng, Y., Chen Y., Shukla, A. J.: Adv. Drug Deliver. Rev., 2003; 55, 1201-1215. Go to original source... Go to PubMed...
    32. Takayama, K., Fujikawa, M., Obata Y., Morishita, M.: Adv. Drug Deliver. Rev., 2003; 55, 1217-1231. Go to original source... Go to PubMed...
    33. Capitán-Vallvey, L. F., Navas, N., del Olmo, M. et al.: Talanta, 2000; 52, 1069-1079. Go to original source...
    34. Alberts, B. et al.: Molecular biology of the cell, second edition. New York, Garland Publishing, 1989, s. 1061.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.